These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 21138144

  • 1. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases.
    Kocak N, Alacacioglu I, Kaynak S, Ozcan MA, Celik O, Yuksel F, Piskin O, Oner H, Saatci AO, Ergin M.
    Ann Ophthalmol (Skokie); 2010; 42 Spec No():10-4. PubMed ID: 21138144
    [Abstract] [Full Text] [Related]

  • 2. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
    Funatsu H, Yamashita H, Mimura T, Noma H, Nakamura S, Hori S.
    Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812
    [Abstract] [Full Text] [Related]

  • 3. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA.
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [Abstract] [Full Text] [Related]

  • 4. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V.
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [Abstract] [Full Text] [Related]

  • 5. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S.
    Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
    [Abstract] [Full Text] [Related]

  • 6. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J, Oficjalska-Młyńczak J.
    Przegl Lek; 2007 Sep; 64(6):389-92. PubMed ID: 18159844
    [Abstract] [Full Text] [Related]

  • 7. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 8. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

  • 9. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 10. Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy.
    Tao Y, Lu Q, Jiang YR, Qian J, Wang JY, Gao L, Jonas JB.
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4237-42. PubMed ID: 20220056
    [Abstract] [Full Text] [Related]

  • 11. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
    Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Uchita M, Matsuzaki T, Takayama M, Shinmura K, Yamada M.
    Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
    [Abstract] [Full Text] [Related]

  • 12. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.
    Wakabayashi Y, Usui Y, Okunuki Y, Kezuka T, Takeuchi M, Goto H, Iwasaki T.
    Retina; 2010 Feb; 30(2):339-44. PubMed ID: 20142713
    [Abstract] [Full Text] [Related]

  • 13. Proinflammatory cytokines and angiogenic and antiangiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease (ED).
    Querques G, Delle Noci N.
    Retina; 2009 Jan; 29(1):121-3; author reply 123. PubMed ID: 18936719
    [No Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE.
    N Engl J Med; 1994 Dec 01; 331(22):1480-7. PubMed ID: 7526212
    [Abstract] [Full Text] [Related]

  • 15. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H, Funatsu H, Mimura T, Harino S, Hori S.
    Ophthalmology; 2009 Jan 01; 116(1):87-93. PubMed ID: 19118700
    [Abstract] [Full Text] [Related]

  • 16. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
    Funatsu H, Yamashita H, Noma H, Mimura T, Sakata K, Hori S.
    Br J Ophthalmol; 2004 Aug 01; 88(8):1064-8. PubMed ID: 15258026
    [Abstract] [Full Text] [Related]

  • 17. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X, Wang G, Wang Y.
    Am J Ophthalmol; 2009 Dec 01; 148(6):883-9. PubMed ID: 19837381
    [Abstract] [Full Text] [Related]

  • 18. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
    Nishimura M, Ikeda T, Ushiyama M, Kinoshita S, Yoshimura M.
    Clin Sci (Lond); 2000 Jan 01; 98(1):9-14. PubMed ID: 10600653
    [Abstract] [Full Text] [Related]

  • 19. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H, Yamashita H, Sakata K, Noma H, Mimura T, Suzuki M, Eguchi S, Hori S.
    Ophthalmology; 2005 May 01; 112(5):806-16. PubMed ID: 15878060
    [Abstract] [Full Text] [Related]

  • 20. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep 01; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.